Search Results for 'Financial Report: AMRI 3Q'

Search For:
Refine by Dates:
From: To:
Refine By Content:

  • Financial Report: BMS

    October 24, 2014
    Revenues down 4% in the quarter

  • Financial Report: AstraZeneca

    October 31, 2013
    Revenues, earnings fall off patent cliff

  • Financial Report: AMRI 3Q10

    November 9, 2010
    Total contract revenue for the quarter was $42.9 million (+8%).

  • AMRI 2Q09

    August 5, 2009
    AMRI's total contract services revenue dropped 16% to $38.8 million in 2Q09

  • Kendle 3Q

    October 31, 2007
    Kendle International 3Q Revenues: $142 million (+47%) 3Q Earnings: $3.7 million (-5%) YTD Revenues: $414 million (+62%) YTD Earnings: $12.3 million (-6%) Comments: Net service revenues grew 33% in 3Q07 to $100 million, and 49% YTD to $…

  • Schering-Plough 3Q

    October 22, 2007
    Schering-Plough 3Q Revenues: $2.8 billion (+9%) 3Q Earnings: $750 million (+142%) YTD Revenues: $9.0 billion (+13%) YTD Earnings: $1.9 billion (+97%) Comments: Revenues do not reflect sales of Vytorin and Zetia, which are accounted as…

  • Financial Report: AMRI

    August 2, 2006
    AMRI 2Q Revenues: $45.6 million (-12%) 2Q Loss: $353,000* (earnings were $7.3 million in 2Q2005) YTD Revenues: $88.9 million (-12%) YTD Earnings: $1.5 million (earnings were $12.9 million YTD2005) Comments: Revenue for Discover…

  • 1Q Financial Report: Fisher Scientific

    May 2, 2006
    Fisher Scientific 1Q Revenues: $1.4 billion (+8%) 1Q Earnings: $103.2 million (+34%) Comments: Income from continuing operations increased to $106.2 million, up 39% for the quarter. Cash from operations totaled $111.2 million, reflecting…

  • 1Q Financial Report: Schering-Plough

    April 20, 2006
    Schering-Plough 1Q Revenues: $2.6 billion (+8%) 1Q Earnings: $350 million (earnings were $105 million in 1Q2005) Comments: The sales increase for the quarter was driven by Remicade, Nasonex, Temodar and Peg-Intron. Remicade sales were u…